Post job

Watson Laboratories company history timeline

1992

Pursuing its nutritional plan further in 1992, Watson purchased Dufar’s nutritional premix division for the food industry and for US AID emergency relief programs.

1994

Watson's revenues rose to $87 million in 1994 as it introduced new drugs to market.

1995

By 1995 Circa, after changing its name from Bolar, was staging a recovery.

1996

By 1996, Watson was still the only pharmaceutical company selling a generic version of the original drug.

1997

In October 1997, Watson secured the United States rights to four G.D. Searle & Co. branded off-patent oral contraceptive products, marking the firm's commitment to expand its women's health business.

In 1997, the company completed two important purchases that brought it closer to its goal and also gave it a foothold in the branded pharmaceuticals market.

2000

2000: The firm purchases Schein Pharmaceutical Inc.

2002

In 2002, the company set plans in motion to launch Oxytrol, the first Watson product developed internally from start to finish.

Sales reached $1.2 billion in 2002 and were expected to continue their upward climb.

Work at Watson Laboratories?
Share your experience
Founded
1992
Company founded
Headquarters
Corona, CA
Company headquarter
Get updates for jobs and news

Rate how well Watson Laboratories lives up to its initial vision.

Zippia waving zebra

Watson Laboratories jobs

Do you work at Watson Laboratories?

Is Watson Laboratories' vision a big part of strategic planning?

Watson Laboratories competitors

Watson Laboratories history FAQs

Zippia gives an in-depth look into the details of Watson Laboratories, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Watson Laboratories. The employee data is based on information from people who have self-reported their past or current employments at Watson Laboratories. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Watson Laboratories. The data presented on this page does not represent the view of Watson Laboratories and its employees or that of Zippia.

Watson Laboratories may also be known as or be related to Watson Laboratories and Watson Laboratories Inc.